Re: Transition, Separation and Consulting AgreementMirum Pharmaceuticals, Inc. • January 9th, 2023 • Pharmaceutical preparations
Company FiledJanuary 9th, 2023 IndustryThis letter sets forth the substance of the transition, separation and consulting agreement (the “Agreement”) that Mirum Pharmaceuticals, Inc. (the “Company”) is offering to you.